Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J7527
    Short Description Oral everolimus
    Long Description Everolimus, oral, 0.25 mg
    Pricing indicator 51
    Coverage code D
    ASC payment group code
    BETOS2 code O1G
    Action code N
    Type of service 1
    Effective date 2014-01-01
    Date Added 2013-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    00054047021 J7527 Oral everolimus Everolimus HIKMA PHARMACEUTICALS USA INC. 0.25 MG 60 1 60 60
    00054047121 J7527 Oral everolimus Everolimus HIKMA PHARMACEUTICALS USA INC. 0.25 MG 60 1 120 120
    00054047221 J7527 Oral everolimus Everolimus HIKMA PHARMACEUTICALS USA INC. 0.25 MG 60 1 180 180
    00078041420 J7527 Oral everolimus Zortress NOVARTIS PHARMACEUTICALS CORPORATION 0.25 MG 60 1 120 120
    00078041520 J7527 Oral everolimus Zortress NOVARTIS PHARMACEUTICALS CORPORATION 0.25 MG 60 1 180 180
    00078041720 J7527 Oral everolimus Zortress NOVARTIS PHARMACEUTICALS CORPORATION 0.25 MG 60 1 60 60
    00078042220 J7527 Oral everolimus ZORTRESS NOVARTIS PHARMACEUTICALS CORPORATION 0.25 MG 60 1 240 240
    49884015802 J7527 Oral everolimus EVEROLIMUS PAR PHARMACEUTICAL 0.25 MG 60 1 60 60
    49884015902 J7527 Oral everolimus EVEROLIMUS PAR PHARMACEUTICAL 0.25 MG 60 1 120 120
    49884016002 J7527 Oral everolimus Everolimus Par Pharmaceutical 0.25 MG 60 1 180 180
    49884028302 J7527 Oral everolimus Everolimus PAR PHARMACEUTICAL 0.25 MG 60 1 240 240
    67877071831 J7527 Oral everolimus Everolimus Ascend Laboratories, Llc 0.25 MG 60 1 60 60
    67877071931 J7527 Oral everolimus Everolimus Ascend Laboratories, Llc 0.25 MG 60 1 120 120
    67877072031 J7527 Oral everolimus Everolimus Ascend Laboratories, Llc 0.25 MG 60 1 180 180
    67877072131 J7527 Oral everolimus Everolimus Ascend Laboratories, Llc 0.25 MG 60 1 240 240
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].